Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Total Current Liabilities: 2022-2024

Historic Total Current Liabilities for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $212.2 million.

  • Immunocore Holdings' Total Current Liabilities fell 36.02% to $170.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.4 million, marking a year-over-year decrease of 36.02%. This contributed to the annual value of $212.2 million for FY2024, which is 52.63% up from last year.
  • Immunocore Holdings' Total Current Liabilities amounted to $212.2 million in FY2024, which was up 52.63% from $139.0 million recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Total Current Liabilities registered a high of $212.2 million during FY2024, and its lowest value of $100.8 million during FY2022.
  • In the last 3 years, Immunocore Holdings' Total Current Liabilities had a median value of $139.0 million in 2023 and averaged $150.7 million.
  • Data for Immunocore Holdings' Total Current Liabilities shows a peak YoY spiked of 52.63% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Immunocore Holdings' Total Current Liabilities stood at $100.8 million in 2022, then soared by 37.87% to $139.0 million in 2023, then spiked by 52.63% to $212.2 million in 2024.